GILEAD SCIENCES, INC. Other Non-current Liabilities 2008-2026 | GILD
Beta
What is GILEAD SCIENCES, INC.'s current other non-current liabilities?
GILEAD SCIENCES, INC. (GILD) annual other non-current liabilities for 2025 was $1.17B, a 10.04% decline from 2024. GILEAD SCIENCES, INC. other non-current liabilities for the quarter ending March 31, 2026 was $1.20B.
What was GILEAD SCIENCES, INC.'s other non-current liabilities in 2024?
GILEAD SCIENCES, INC. annual other non-current liabilities for 2024 was $1.29B, a 1.17% increase from 2023.
What was GILEAD SCIENCES, INC.'s other non-current liabilities in 2023?
GILEAD SCIENCES, INC. annual other non-current liabilities for 2023 was $1.28B, a 8.57% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year other non-current liabilities CAGR?
GILEAD SCIENCES, INC. other non-current liabilities grew at a compound annual growth rate (CAGR) of 0.82% from FY2020 to FY2025, going from $1.21B to $1.17B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-0.8%
FY2020
$1.21B
→
FY2025
$1.17B
080910111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.17B | -10.0% | 10-K |
| FY2024 | $1.29B | +1.2% | 10-K |
| FY2023 | $1.28B | +8.6% | 10-K |
| FY2022 | $1.18B | +20.8% | 10-K |
| FY2021 | $976.0M | -19.6% | 10-K |
| FY2020 | $1.21B | +20.3% | 10-K |
| FY2019 | $1.01B | -3.0% | 10-K |
| FY2018 | $1.04B | +86.4% | 10-K |
| FY2017 | $558.0M | +87.9% | 10-K |
| FY2016 | $297.0M | -24.8% | 10-K |
| FY2015 | $395.0M | -32.6% | 10-K |
| FY2014 | $586.0M | +227.4% | 10-K |
| FY2013 | $179.0M | -28.4% | 10-K |
| FY2012 | $250.0M | +69.2% | 10-K |
| FY2011 | $147.7M | +439.2% | 10-K |
| FY2010 | $27.4M | -23.7% | 10-K |
| FY2009 | $35.9M | +67.4% | 10-K |
| FY2008 | $21.5M | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →